AbbVie Inc. (NYSE:ABBV) is one of the 7 most undervalued pot stocks to buy according to analysts. On July 3, the company ...

GE Aerospace (GE) will release its second quarter 2025 financials on Thursday, July 17. Shares of the company have been on a strong upward trajectory this year, with its stock soaring more than 55% ...

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed President Trump’s threat to impose 35% tariffs on ...

Arm Holdings' drastically higher short interest and overly exuberant market sentiments imply near-term volatility. Learn more ...

Palantir’s strong revenue growth, high retention, and major government contracts highlight its AI leadership. Find out why PLTR stock is a strong buy.

Over the past three years, this stock has vastly outperformed the FTSE 250. Dr James Fox takes a closer look at this little-known organisation. The post Up 185% in 3 years, why does the market love ...

Sterling Infrastructure, Inc. (STRL) and Tutor Perini Corporation (TPC) are tapping into a robust infrastructure cycle with a ...

CVS Health (CVS - Free Report) has an Earnings ESP of +2.06% and a Zacks Rank #2 at present. The company is slated to release second-quarter 2025 results on July 31. You can see the complete list of ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

The announcement from Wells Fargo is eagerly anticipated, with investors seeking news of surpassing estimates and favorable ...

Preferred Bank (PFBC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...